A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Clinical Trial ID NCT02053792

PubWeight™ 3.34‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02053792

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov 2014 2.20
2 New developments in the management of moderate-to-severe hemophilia B. J Blood Med 2016 0.82
3 Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial. Thromb Haemost 2016 0.76
Next 100